
What smart money is saying about ASKA Pharmaceutical Holdings Co Ltd
1 fund in our archive has pitched ASKA Pharmaceutical Holdings Co Ltd — most recently NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc in December 2025.
ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.
Position history
Every position in ASKA Pharmaceutical Holdings Co Ltd on record in the archive was reported in Q4 2025, across 1 fund letter, with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q4 2025 | 1 | 0 | 0 | 1 |
Fund activity · 1 position
- HoldsNAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plcDecember 2025
Listed in NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plc’s reported holdings.
Read the letterASKA Pharmaceutical Holdings Co Ltd
Fund coverage · 1 thesis
- NAVF (Rising Sun Management / Dalton) Nippon Active Value Fund plcDecember 2025
ASKA Pharmaceutical Holdings is supported by stronger growth, higher margins and ROE targets, and a strategy focused on women’s health, overseas expansion, and pipeline monetization.
Read the full thesis
Read every full thesis on ASKA Pharmaceutical Holdings Co Ltd
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→